Dr Lal PathLabs Q3 net down 7% to Rs 54 cr, revenue declines to Rs 489 cr

Shares of the company were trading 1.63 per cent down at Rs 2,019.15 apiece on the BSE

Dr Lal PathLabs
The company had reported a net profit of Rs 58 crore in the October-December quarter of the previous fiscal
Press Trust of India New Delhi
1 min read Last Updated : Feb 02 2023 | 3:54 PM IST

Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 7 per cent to Rs 54 crore for the December quarter.

The company had reported a net profit of Rs 58 crore in the October-December quarter of the previous fiscal.

Revenue also declined to Rs 489 crore for the period under review as compared with Rs 497 crore in the year-ago period, the company said in a regulatory filing.

"We continue to focus on geographical expansion and strengthen our presence in Tier 2, Tier 3 towns. Our focus continues to take a higher market share in West and South markets by leveraging technology and promoting high-end super specialty test portfolios," Dr Lal PathLabs Managing Director Om Manchanda said.

Shares of the company were trading 1.63 per cent down at Rs 2,019.15 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Dr Lal PathLabsQ3 results

First Published: Feb 02 2023 | 3:54 PM IST

Next Story